Offstream
news

A trial of a plant-based COVID-19 vaccine conducted by GSK and Medicago shows an overall 71% efficacy against disease caused by the predominant SARS-CoV-2 variants of concern observed during most of 2021, and 75% efficacy specifically against disease caused by Delta. The study excludes the Omicron variant, which was not in circulation at the time of the clinical trials.
2021-12-7

The Medicines and Healthcare products Regulatory Agency approves GSK and Vir Biotechnology's sotrovimab antibody treatment, after a clinical trial found that the treatment reduced the risk of hospital admission and death by 79% in vulnerable adults if administered within five days of symptoms developing.
2021-12-2

The Health Ministry panel committee approve the usage of the single-dose monoclonal antibody-based treatment sotrovimab developed by GlaxoSmithKline and Vir Biotechnology to treat mild and moderately-ill COVID-19 patients.
2021-09-27

GlaxoSmithKline and Sanofi begins new clinical trial of their protein-based vaccine candidate and aim to reach the final testing stage in the second quarter after setback last year.
2021-02-22

The United States government is expected to pay $2.1 billion to Sanofi and GlaxoSmithKline to try to develop and deliver 100 million doses of their potential COVID-19 vaccine.
2020-07-31

China fines Glaxosmithkline US$490 million for its alleged involvement in a bribery scandal.
2014-09-19

British pharmaceutical company GlaxoSmithKline admits that some of its senior executives in China appear to have broken the law as part of a bribery scandal.
2013-07-22

GlaxoSmithKline pays out $3.4 billion last quarter in legal settlings over their drug Avandia.
2011-01-17

GlaxoSmithKline pleads guilty to intentionally manufacturing and distributing adulterated drugs, including Paxil, and will pay $750 million for committing the felony.
2010-10-26

Files indicate that GlaxoSmithKline knew Rosiglitazone (Avandia) had high heart risks since 1999, and made efforts to cover up the findings.
2010-07-12